apraclonidine
SMILES | Nc1cc(Cl)c(c(c1)Cl)NC1=NCCN1 |
InChIKey | IEJXVRYNEISIKR-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 4 |
Hydrogen bond donors | 3 |
Rotatable bonds | 1 |
Molecular weight (Da) | 244.0 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.5 | 8.5 | 8.5 | Guide to Pharmacology |
α2B | ADA2B | Rat | Adrenoceptors | A | pKi | 8.32 | 8.32 | 8.32 | ChEMBL |
α2B | ADA2B | Human | Adrenoceptors | A | pKi | 7.53 | 7.94 | 8.35 | PDSP Ki database |
α2A | ADA2A | Pig | Adrenoceptors | A | pKi | 6.54 | 6.54 | 6.54 | PDSP Ki database |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.1 | 8.1 | 8.1 | PDSP Ki database |
α2C | ADA2C | Human | Adrenoceptors | A | pKi | 7.67 | 7.67 | 7.67 | PDSP Ki database |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.07 | 8.07 | 8.07 | Drug Central |
α2B | ADA2B | Human | Adrenoceptors | A | pKi | 8.1 | 8.1 | 8.1 | Drug Central |
α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.12 | 8.12 | 8.12 | Drug Central |
α2B | ADA2B | Rat | Adrenoceptors | A | pKi | 8.08 | 8.08 | 8.08 | Drug Central |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.54 | 8.54 | 8.54 | ChEMBL |
α2C | ADA2C | Human | Adrenoceptors | A | pKi | 7.52 | 7.52 | 7.52 | ChEMBL |
α2C | ADA2C | Human | Adrenoceptors | A | pKi | 7.52 | 7.52 | 7.52 | Guide to Pharmacology |
D2 | DRD2 | Rat | Dopamine | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
TSH | TSHR | Human | Glycoprotein hormone | A | Potency | 4.5 | 4.5 | 4.5 | ChEMBL |
M1 | ACM1 | Rat | Acetylcholine (muscarinic) | A | Potency | 4.55 | 4.55 | 4.55 | ChEMBL |